Enlightenment Research’s Encompass Health EHC Stock Holding History

Enlightenment Research’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-503	Closed	-$25K	–	267
2018 Q4	$25K	Buy	+503	New	+$28.6K	0.03%	397

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Enlightenment Research's EHC Position: Q1 2019 in Review

Enlightenment Research sold out of Encompass Health (EHC) in Q1 2019, closing a stake of 503 shares — an estimated $25K sold.

Enlightenment Research first reported a position in EHC in Q4 2018 and held it in 1 quarter. The position peaked at $25K in Q4 2018. 427 funds tracked by Wall St. Rank hold EHC as of Q1 2019.

Enlightenment Research reported no remaining Encompass Health position as of Q1 2019 after selling out during the quarter.
Enlightenment Research sold 503 Encompass Health shares in Q1 2019, an estimated $25K.
Enlightenment Research first reported a position in Encompass Health in Q4 2018 and held it in 1 quarter.
Enlightenment Research's Encompass Health position peaked at $25K in Q4 2018.
427 funds tracked by Wall St. Rank held Encompass Health as of Q1 2019.

Based on Enlightenment Research's 13F filing for Q1 2019, filed 3 May 2019.